Your browser doesn't support javascript.
loading
Enhancing the Impact of Genomics Research in Autism through Integration of Research Results into Routine Care Pathways-A Case Series.
Peltekova, Iskra; Buhas, Daniela; Stern, Lara; Kirby, Emily; Yusuf, Afiqah; Elsabbagh, Mayada.
Afiliação
  • Peltekova I; McGill University Health Centre, McGill University, Montreal, QC H3A 0G4, Canada.
  • Buhas D; Montreal Children's Hospital, McGill University Health Centre, Montreal, QC M4A 3J1, Canada.
  • Stern L; McGill University Health Centre, McGill University, Montreal, QC H3A 0G4, Canada.
  • Kirby E; Montreal Children's Hospital, McGill University Health Centre, Montreal, QC M4A 3J1, Canada.
  • Yusuf A; McGill University Health Centre, McGill University, Montreal, QC H3A 0G4, Canada.
  • Elsabbagh M; Montreal Children's Hospital, McGill University Health Centre, Montreal, QC M4A 3J1, Canada.
J Pers Med ; 11(8)2021 Jul 30.
Article em En | MEDLINE | ID: mdl-34442399
ABSTRACT
The return of genetic results (RoR) to participants, enrolled as children, in autism research remains a complex process. Existing recommendations offer limited guidance on the use of genetic research results for clinical care. We highlight current challenges with RoR and illustrate how the use of a guiding framework drawn from existing literature facilitates RoR and the clinical integration of genetic research results. We report a case series (n = 16) involving the return of genetic results to participants in large genomics studies in Autism Spectrum Disorders (ASD). We outline the framework that guided RoR and facilitated integration into clinical care pathways. We highlight specific cases to illustrate challenges that were, or could have been, resolved through this framework. The case series demonstrates the ethical, clinical and practical difficulties of RoR in ASD genomic studies for participants enrolled as children. Challenges were resolved using pre-established framework to guide RoR and incorporate research genetic results into clinical care. We suggest that optimal use of genetic research results relies on their integration into individualized care pathways for participants. We offer a framework that attempts to bridge the gap between research and healthcare in ASD.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article